Search research articles
Contact Us
Filters
Showing results (41-50 of 102) with videos related to
Page
of 11
Sort By:
Tumori
|
March 1, 1996
[Long-term hematopoietic reconstitution after myeloablative antitumor therapy and circulating hematopoietic stem cell transplantation]
S Siena, M Bregni, M Di Nicola, et al.
Cancer Research
|
June 15, 1989
Immunotoxin-mediated inhibition of chronic lymphocytic leukemia cell proliferation in humans
S Siena, M Bregni, A Formosa, et al.
Haematologica
|
May 9, 1998
Mobilized peripheral blood CD34+ cells express more amphotropic retrovirus receptor than bone marrow CD34+ cells
M Bregni, M Di Nicola, S Siena, et al.
Journal of the National Cancer Institute
|
June 1, 1988
Activity of a monoclonal antibody-saporin-6 conjugate against B-lymphoma cells
M Bregni, D A Lappi, S Siena, et al.
Bone Marrow Transplantation
|
August 1, 1990
Durable and complete hematopoietic reconstitution after autografting of rhGM-CSF exposed peripheral blood progenitor cells
A M Gianni, C Tarella, S Siena, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2002
Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer
P Corradini, C Voena, M Astolfi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1992
Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients
A M Gianni, M Bregni, S Siena, et al.
Haematologica
|
March 1, 1991
Methodologies to estimate circulating hematopoietic progenitors for autologous transplantation in cancer patients
F Ravagnani, S Siena, M Bregni, et al.
Blood
|
May 1, 1985
Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement
P De Fabritiis, M Bregni, J Lipton, et al.
Cancer Research
|
January 4, 1998
Autologous dendritic cells derived from CD34+ progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of melan-A/Mart-1(27-35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors
R Mortarini, A Anichini, M Di Nicola, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 102) with videos related to
Sort By:
Page
of 11
Tumori
|
March 1, 1996
[Long-term hematopoietic reconstitution after myeloablative antitumor therapy and circulating hematopoietic stem cell transplantation]
S Siena, M Bregni, M Di Nicola, et al.
Cancer Research
|
June 15, 1989
Immunotoxin-mediated inhibition of chronic lymphocytic leukemia cell proliferation in humans
S Siena, M Bregni, A Formosa, et al.
Haematologica
|
May 9, 1998
Mobilized peripheral blood CD34+ cells express more amphotropic retrovirus receptor than bone marrow CD34+ cells
M Bregni, M Di Nicola, S Siena, et al.
Journal of the National Cancer Institute
|
June 1, 1988
Activity of a monoclonal antibody-saporin-6 conjugate against B-lymphoma cells
M Bregni, D A Lappi, S Siena, et al.
Bone Marrow Transplantation
|
August 1, 1990
Durable and complete hematopoietic reconstitution after autografting of rhGM-CSF exposed peripheral blood progenitor cells
A M Gianni, C Tarella, S Siena, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2002
Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer
P Corradini, C Voena, M Astolfi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1992
Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients
A M Gianni, M Bregni, S Siena, et al.
Haematologica
|
March 1, 1991
Methodologies to estimate circulating hematopoietic progenitors for autologous transplantation in cancer patients
F Ravagnani, S Siena, M Bregni, et al.
Blood
|
May 1, 1985
Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement
P De Fabritiis, M Bregni, J Lipton, et al.
Cancer Research
|
January 4, 1998
Autologous dendritic cells derived from CD34+ progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of melan-A/Mart-1(27-35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors
R Mortarini, A Anichini, M Di Nicola, et al.
Page
of 11